Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Go back to Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs
(NASDAQ: KZIA) Delayed: 12.03 -0.66 (5.2%)
Previous Close $12.69    52 Week High
Open $12.64    52 Week Low
Day High $13.22    P/E N/A 
Day Low $11.78    EPS
Volume 162,214